Scarica l'app Stockscreener
4.69
1.52%
0.07
Dopo l'orario di chiusura:
4.69
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System Updates - Insider Monkey
Cytek Biosciences unveils 21-color T-cell kit to boost immunoprofiling workflows - Traders Union
Aug Action: Can Cytek Biosciences Inc sustain its profitabilityMarket Growth Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Millennium Group reports 6.64M shares in Cytek Biosciences (CTKB) - Stock Titan
Cytek Biosciences streamlines drop charge optimization for small sample workflows - Traders Union
Stock Market Recap: Is Cytek Biosciences Inc stock showing strong momentumTrade Performance Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates - MSN
Cytek Biosciences, Inc. (8EQ.F) stock price, news, quote and history - Yahoo Finance UK
Tudor Investment Corp ET AL Invests $867,000 in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives $5.38 Consensus PT from Analysts - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Vanguard realignment leaves Cytek (NASDAQ: CTKB) ownership at 0 after amendment - Stock Titan
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - sahmcapital.com
EPS Watch: What is the Moat Score of Cytek Biosciences Inc2026 Rallies & Smart Allocation Stock Reports - baoquankhu1.vn
Cytek Biosciences, Inc. (CTKB) Stock Forecasts - Yahoo Finance
Cytek Biosciences outlines $205M–$212M 2026 revenue target amid record Q4 and growth in recurring revenue - MSN
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
CTKB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cytek Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Topline Capital Management LLC Has $24.10 Million Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
US Stocks Recap: How does Cytek Biosciences Inc compare to its peersMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Cytek Biosciences (CTKB) director converts 6,107 RSUs into common stock - Stock Titan
Cytek Biosciences (CTKB) CLO receives new options, 226,453 RSUs and stock from vesting - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) SVP granted options, RSUs and sees RSU vesting - Stock Titan
Cytek Biosciences (CTKB) CEO awarded options, RSUs and surrenders shares for taxes - Stock Titan
Cytek Biosciences (CTKB) CFO receives new equity awards and RSU vesting - Stock Titan
Cytek Biosciences (CTKB) CTO granted stock options and 227,535 RSUs - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) director gains 2,908 shares via RSU vesting - Stock Titan
Latest CTKB NewsAmberstone Biosciences Secures $12 Million ... - Stock Titan
Sell Signal: What is the Moat Score of Cytek Biosciences IncTrade Performance Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - The Manila Times
Cytek Biosciences expands global reach with one year of Singapore operations - Traders Union
Cytek Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Bitget
Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference - Yahoo Finance
How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance - Yahoo Finance
Cytek Biosciences Balances Growth With Margin Strain - The Globe and Mail
Cytek Biosciences, Inc. (CTKB) Presents at TD Cowen 46th Annual Health Care ConferenceSlideshow - Seeking Alpha
Royce & Associates LP Increases Holdings in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives $5.50 Average PT from Brokerages - Defense World
CTKB SEC FilingsCytek Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Cytek Biosciences at TD Cowen Health Care: Strategic Growth Insights By Investing.com - Investing.com Canada
Cytek Biosciences at TD Cowen Health Care: Strategic Growth Insights - Investing.com India
Buyback Watch: What is the Moat Score of Cytek Biosciences IncStop Loss & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
CTKB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cytek Biosciences outlines cell sorting breakthroughs in webinar - Traders Union
Cytek Biosciences, Inc. (NASDAQ:CTKB) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2025 Earnings Call Transcript - Insider Monkey
Cytek (CTKB) Q4 2025 Earnings Call Transcript - AOL.com
Cytek Biosciences (NASDAQ:CTKB) Announces Quarterly Earnings Results, Misses Estimates By $0.36 EPS - MarketBeat
Earnings call transcript: Cytek Biosciences Q4 2025 sees record revenue, EPS miss - Investing.com South Africa
Cytek Biosciences, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Cytek Biosciences, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:CTKB) 2026-02-27 - Seeking Alpha
Cytek Biosciences earnings missed by $0.32, revenue topped estimates - Investing.com Canada
Cytek Biosciences Q4 Earnings Call Highlights - Yahoo Finance
Earnings Call Summary | Cytek Biosciences(CTKB.US) Q4 2025 Earnings Conference - 富途牛牛
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates - Nasdaq
Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings - ChartMill
2.40%
0.00%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):